In this Oncology Brothers podcast episode, Naval Daver, MD, MD Anderson Cancer Center, Houston, Texas, discusses treatment strategies for both therapy‑related and de novo acute myeloid leukemia (AML), focusing on cases…
Tara Lin, MD, University of Kansas Medical Center, Kansas City, Kansas, discusses how she approaches choosing induction therapy for patients with treatment-related acute myeloid leukemia, emphasizing that fitness…
Each month we present you with the latest featured study from the research teams at JAMA, Journal of the American Medical Association. Check out the video for intriguing…
Julio A. Aguirre-Ghiso, PhD, Professor of Medicine, Hematology, and Medical Oncology at the Tisch Cancer Institute Icahn School of Medicine at Mount Sinai, is leading a study on…
Neural networks (a.k.a. deep learning algorithms) can be used to teach computers to distinguish various types of disease via prior analysis of massive amounts of clinical data.
While influenza vaccination remains the top recommendation of physicians for protecting against the flu, there are other preventive measures that still need to become more widely adopted. Many…
Immunotherapy with newly developed “immune checkpoint inhibitors” has led to striking advances in treatment for aggressive malignancies such as melanoma, non-small cell lung cancer, and renal cell carcinoma.…
The Proteomic Assessment of Preterm Birth (PAPR) study conducted by Sera Prognostics, Inc. has yielded information that led to the development of a test which can help physicians…
New research is helping scientists better understand gene modification’s effects on many forms of bladder cancer. Additionally, results from numerous recent studies seem to foreshadow a change of…
Astronaut Scott Kelly, and his twin brother (retired astronaut) Mark, are part of an ongoing NASA study examining the differences in immune responses to influenza and other pathogens…
